Brendan Manning

@bdmanning.bsky.social did:plc:fw4u6lmcxtcomsiedc4t7ocf

Scientist working on signaling and metabolism in cancer, metabolic diseases, aging, and physiology. AKT-TSC-mTOR🧪

No Bluesky desde 21 novembro 2024

Resumo

Brendan Manning (@bdmanning.bsky.social) é um usuário do Bluesky desde 21 novembro 2024. Tem 848 seguidores, segue 144 contas e publicou 30 posts.

Os melhores dias em que posts desta conta entraram na lista diária do Debya.

Esta conta ainda não apareceu em um ranking diário.

Curtidas públicas da rede Bluesky.

Cristina Muñoz Pinedo@crismunozp.bsky.social21/04/2026 14:33
Unless she studies bile acids, of course. Then metabilism is appropriate
Ver post
cniostopcancer.bsky.social@cniostopcancer.bsky.social17/04/2026 23:14
✍️ Registration open: bit.ly/45jaORu Sponsored by @caixaresearch.bsky.social @fendtlab.bsky.social @arkaitzcarracedo.bsky.social @bdmanning.bsky.social
Ver post
Cristina Muñoz Pinedo@crismunozp.bsky.social17/04/2026 23:13
So cool to have Trends in Endocrinology and Metabolism highlighting research from the lab! Thanks @bdmanning.bsky.social @cp-trendsendomet.bsky.social www.sciencedirect.com/science/arti...
Ver post
James Olzmann@olzmannlab.bsky.social12/12/2025 20:45
Happy to see our News & Views is out! We highlight two landmark papers demonstrating the potential for therapeutic targeting of FSP1 and #ferroptosis in in vivo cancer models. Beautiful work from @ubellackerlab.bsky.social, Thales Papagiannakopoulos, and colleagues. 🥳 www.nature.com/articles/s41...
Ver post
ASBMB Journals@asbmbjournals.bsky.social22/11/2025 22:37
Biochemical modifications help control cell function — and their disruption contributes to cancer, metabolic disease and neurodegeneration. Join the #JBiolChem symposium organized by @alextoker.bsky.social to explore new research and emerging therapeutic insights: ow.ly/GtMz50Xwbo0.
Ver post

No Bluesky, bloqueios são registros públicos.

Esta conta não bloqueia ninguém.